Led by Robert Bone, PhD, assistant professor at the Novo Nordisk Foundation Center for Stem Cell Medicine (reNEW), the ...

In a new study, researchers from the University of Copenhagen have successfully created stem cells that are better at ...

The ‘super stem cells’ perform better than regular stem cells, being able to develop into many different cell types, ...

By integrating CRISPR-Cas9 induced gene editing with single cell RNA-Seq, high-resolution lineage tracing through molecular barcoding becomes feasible. However, tracking mutation evolution across ...

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, and the Christopher & Dana ...

Although many may successfully disseminate, variation exists in the efficiency with which circulating tumor cells home to and invade the bone marrow as metastastic seeds. Disseminated tumor cells ...

X denotes truncating mutation. PEST2 domain 345–377; UBA domain 387–436. *Two different mutations reported to cause this truncation. ‡ Results from splice site mutations (intron 7 ...

UHN Princess Margaret Cancer Centre, Toronto, Ontario, Canada.

Halda Therapeutics, a clinical-stage biotechnology company developing a novel class of cancer therapies called RIPTACTM (Regulated Induced Proximity Targeting Chimeras) therapeutics, today announced ...